Literature DB >> 31370004

The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

Jessica L Pierce1, Ke-Hong Ding2, Jianrui Xu3, Anuj K Sharma4, Kanglun Yu5, Natalia Del Mazo Arbona6, Zuleika Rodriguez-Santos7, Paul Bernard8, Wendy B Bollag9, Maribeth H Johnson10, Mark W Hamrick11, Dana L Begun12, Xing M Shi13, Carlos M Isales14, Meghan E McGee-Lawrence15.   

Abstract

Excess fat within bone marrow is associated with lower bone density. Metabolic stressors such as chronic caloric restriction (CR) can exacerbate marrow adiposity, and increased glucocorticoid signaling and adrenergic signaling are implicated in this phenotype. The current study tested the role of glucocorticoid signaling in CR-induced stress by conditionally deleting the glucocorticoid receptor (GR) in bone marrow osteoprogenitors (Osx1-Cre) of mice subjected to CR and ad libitum diets. Conditional knockout of the GR (GR-CKO) reduced cortical and trabecular bone mass as compared to wildtype (WT) mice under both ad libitum and CR conditions. No interaction was detected between genotype and diet, suggesting that the GR is not required for CR-induced skeletal changes. The lower bone mass in GR-CKO mice, and the further suppression of bone by CR, resulted from suppressed bone formation. Interestingly, treatment with the -adrenergic receptor antagonist propranolol mildly but selectively improved metrics of cortical bone mass in GR-CKO mice during CR, suggesting interaction between adrenergic and glucocorticoid signaling pathways that affects cortical bone. GR-CKO mice dramatically increased marrow fat under both ad libitum and CR-fed conditions, and surprisingly propranolol treatment was unable to rescue CR-induced marrow fat in either WT or GR-CKO mice. Additionally, serum corticosterone levels were selectively elevated in GR-CKO mice with CR, suggesting the possibility of bone-hypothalamus-pituitary-adrenal crosstalk during metabolic stress. This work highlights the complexities of glucocorticoid and β-adrenergic signaling in stress-induced changes in bone mass, and the importance of GR function in suppressing marrow adipogenesis while maintaining healthy bone mass.

Entities:  

Year:  2019        PMID: 31370004      PMCID: PMC6938567          DOI: 10.1530/JOE-19-0230

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  76 in total

Review 1.  Neuronal signaling and the regulation of bone remodeling.

Authors:  F Elefteriou
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

2.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Authors:  R S Weinstein; R L Jilka; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

3.  Blocking β-adrenergic signaling attenuates reductions in circulating leptin, cancellous bone mass, and marrow adiposity seen with dietary energy restriction.

Authors:  Kyunghwa Baek; Susan A Bloomfield
Journal:  J Appl Physiol (1985)       Date:  2012-09-20

4.  Corticosterone rhythm of mouse adrenal in relation to serum corticosterone and sampling.

Authors:  F HALBERG; P G ALBRECHT; J J BITTNER
Journal:  Am J Physiol       Date:  1959-11

Review 5.  Metabolic functions of glucocorticoid receptor in skeletal muscle.

Authors:  Taiyi Kuo; Charles A Harris; Jen-Chywan Wang
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

6.  T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.

Authors:  Judson A Brewer; Bernard Khor; Sherri K Vogt; Lisa M Muglia; Hideji Fujiwara; Karen E Haegele; Barry P Sleckman; Louis J Muglia
Journal:  Nat Med       Date:  2003-08-31       Impact factor: 53.440

7.  A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.

Authors:  Sari L Alatalo; Zhiqi Peng; Anthony J Janckila; Helena Kaija; Pirkko Vihko; H Kalervo Vaananen; Jussi M Halleen
Journal:  J Bone Miner Res       Date:  2003-01       Impact factor: 6.741

8.  PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.

Authors:  Qing-Hua Zhao; Shou-Guo Wang; Shao-Xian Liu; Ji-Peng Li; Yong-Xing Zhang; Zhong-Yi Sun; Qi-Ming Fan; Ji-Wei Tian
Journal:  FEBS J       Date:  2013-09-13       Impact factor: 5.542

9.  Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.

Authors:  Trevor Teich; Emily C Dunford; Deanna P Porras; Jacklyn A Pivovarov; Jacqueline L Beaudry; Hazel Hunt; Joseph K Belanoff; Michael C Riddell
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-03       Impact factor: 4.310

Review 10.  It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions.

Authors:  Mark Nixon; Ruth Andrew; Karen E Chapman
Journal:  Steroids       Date:  2012-11-02       Impact factor: 2.668

View more
  4 in total

Review 1.  Bone marrow adipose tissue in metabolic health.

Authors:  Gisela Pachón-Peña; Miriam A Bredella
Journal:  Trends Endocrinol Metab       Date:  2022-04-05       Impact factor: 10.586

Review 2.  Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases.

Authors:  Sooyeon Lee; Benjamin Thilo Krüger; Anita Ignatius; Jan Tuckermann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-10       Impact factor: 5.555

3.  Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.

Authors:  Holger Henneicke; Sarah Kim; Michael M Swarbrick; Jingbao Li; Sylvia J Gasparini; Joanne Thai; Daphne Foong; Lauryn L Cavanagh; Colette Fong-Yee; Elisabeth Karsten; Ruby C Y Lin; Mark S Cooper; Hong Zhou; Markus J Seibel
Journal:  Mol Metab       Date:  2020-10-10       Impact factor: 7.422

4.  Report From the 6th International Meeting on Bone Marrow Adiposity (BMA2020).

Authors:  Erica L Scheller; Meghan E McGee-Lawrence; Beata Lecka-Czernik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.